Novavax, Inc. (NVAX)
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
NVAX Stock Chart More Charts
NVAX Price/Volume Stats
| Current price | $2.05 |
| Prev. close | $2.10 |
| Day low | $2.00 |
| Day high | $2.12 |
| 50-day MA | $2.00 |
| 200-day MA | $1.70 |
| 52-week high | $2.75 |
| 52-week low | $1.15 |
| Volume | 10,089,700 |
| Avg. volume | 10,656,123 |
| Dividend yield | N/A |
| Market Cap | 784.84M |
NVAX Returns
| 1-mo | 0.00% |
| 3-mo | 8.47% |
| 6-mo | 45.39% |
| 1-year | 4.06% |
| 3-year | -66.94% |
| 5-year | -66.56% |
| YTD | 11.41% |
| 2018 | 48.39% |
| 2017 | -1.59% |
| 2016 | -84.98% |
| 2015 | 41.48% |
| 2014 | 15.82% |
Loading social stream, please wait...